Verastem | VSTM - Operating Profit

Verastem reported $-16846000 in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Abbvie ABBV:US USD 5.5B 899M
AstraZeneca AZN:LN USD 1.09B 151M
Curis CRIS:US USD -10220000 2.39M
Cytokinetics CYTK:US USD -127030000 3.66M
Gilead Sciences GILD:US USD 2.27B 570M
Immunogen IMGN:US USD -59559000 17.87M
Laboratory Of America LH:US USD 90.7M 378.7M
Novartis NOVN:VX USD 1.95B 219M
Pfizer PFE:US USD 5.17B 4.24B
Roche Holding ROG:VX 5.93B 5.62B
Tg Therapeutics TGTX:US USD -52062000 17.1M
Verastem VSTM:US USD -16846000 863K
YTE INCY:US USD 70.09M 68.28M
Ziopharm Oncology ZIOP:US USD -8521000 257K